|
|
Volumn 36, Issue 8, 1997, Pages 445-448
|
|
Fluoroquinolone therapy in pediatrics: Where we stand
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
CIPROFLOXACIN;
NORFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TOBRAMYCIN;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
ARTHRALGIA;
BACTERIAL INFECTION;
CHILD;
CHILDHOOD DISEASE;
CLINICAL TRIAL;
CONJUNCTIVITIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
EDITORIAL;
GASTROINTESTINAL TOXICITY;
GRAM NEGATIVE INFECTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
MULTIDRUG RESISTANCE;
ORAL DRUG ADMINISTRATION;
PSEUDOMONAS AERUGINOSA;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SALMONELLA;
TOPICAL DRUG ADMINISTRATION;
TREATMENT INDICATION;
|
|
EID: 0030843321
PISSN: 00099228
EISSN: None
Source Type: Journal
DOI: 10.1177/000992289703600802 Document Type: Editorial |
|
Times cited : (1)
|
|
References (36)
|
